Effects of protracted administration of estriol on the lower genito urinary tract in postmenopausal women. - Iosif CS - Arch Gynecol Obstet - 01-JAN-1992; 251(3): 115-20 (From NIH/NLM MEDLINE): 80 postmenopausal women with symptoms of vaginal atrophy and urinary incontinence, 8-10 years of treatment, 75% of the women reported significant subjective improvement of stress incontinence, and the risk of estriol treatment is insignificant.
Schar G, et al, Effect of vaginal estrogen therapy on urinary incontinence in postmenopause. Zentralbl Gynakol 1995; 117:77-80 (article in German) 135 women, 3.5 mg estriol intravaginally x 3 months, 63% reported significant improvement in incontinence
John R. Lee, M.D. with Virginia Hopkins. What your Doctor may not tell you about menopause. The breakthrough book on natural progesterone. Warner Books, Inc. 1996
Tzay-Shing Yang M.D. et al., Efficacy and safety of estriol replacement therapy for climacteric women. Chin Med J (Taipei) 1995;55:386-91
A. H. Follingstad M.D. Estriol, the forgotten estrogen. JAMA, Jan. 2 1978 Vol 239 No.1.
Hiroshi Minaguchi M.D. et al, Yokohama City University, School of Medicine, Yokohama, Japan. J. Obstet. Gynaecol. Res. Vol 22, No. 3: 259-265 1996.
Raul Raz, M.D., Walter E. Stamm, M.D. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N. England J. Med. 1993;329:753-6.
G. P. Vooijs, T. B. P. Geurts, Review of the endometrial safety during intravaginal treatment with estriol. European Journal of Obstet. and Gynec. and Reprod. Biology 62 (1995) 101-106.
Dessole S. et al. Menopause. 2004; 11:49-56
Menopause. 2004; Jan-Feb;11(1):49-56. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Dessole S, Rubattu G, Gallo O, Capobianco G, Cherchi PL, Marci R, Cosmi E. Locate on PubMed with PMID: 14716182